- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the Wnt/β-catenin signaling pathway in cancer
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-12-04
DOI
10.1186/s13045-020-00990-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Curcumin therapeutic modulation of the Wnt signaling pathway
- (2020) Amirhossein Sahebkar et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Targeting Wnt/β‐catenin and PI3K/Akt/mTOR pathways in T‐cell acute lymphoblastic leukemia
- (2020) Cecilia Evangelisti et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Antiepileptic Drug Carbamazepine Binds to a Novel Pocket on the Wnt Receptor Frizzled-8
- (2020) Yuguang Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Chelerythrine Chloride Downregulates β-Catenin and Inhibits Stem Cell Properties of Non-Small Cell Lung Carcinoma
- (2020) Win Sen Heng et al. MOLECULES
- The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation
- (2020) Tao Liu et al. NUCLEIC ACIDS RESEARCH
- Inhibiting WNT and NOTCH in renal cancer stem cells and the implications for human patients
- (2020) Annika Fendler et al. Nature Communications
- Inhibition of Wnt signalling pathway by XAV939 enhances radiosensitivity in human cervical cancer HeLa cells
- (2020) Jinhua Zhang et al. Artificial Cells Nanomedicine and Biotechnology
- Echinacoside inhibits breast cancer cells by suppressing the Wnt/β-catenin signaling pathway
- (2020) Chenghuai Tang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Blockade of β-Catenin–Induced CCL28 Suppresses Gastric Cancer Progression via Inhibition of Treg Cell Infiltration
- (2020) Lu Ji et al. CANCER RESEARCH
- Destabilization of β-catenin and RAS by targeting the Wnt/β-catenin pathway as a potential treatment for triple-negative breast cancer
- (2020) Won-Ji Ryu et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Emerging agents that target signaling pathways in cancer stem cells
- (2020) Yue Yang et al. Journal of Hematology & Oncology
- Discovery of Novel Inhibitor for WNT/β-Catenin Pathway by Tankyrase 1/2 Structure-Based Virtual Screening
- (2020) Bo Li et al. MOLECULES
- Overcoming Wnt–β-catenin dependent anticancer therapy resistance in leukaemia stem cells
- (2020) John M. Perry et al. NATURE CELL BIOLOGY
- Targeting the β-catenin signaling for cancer therapy
- (2020) Xue Zhang et al. PHARMACOLOGICAL RESEARCH
- GDE2-Dependent Activation of Canonical Wnt Signaling in Neurons Regulates Oligodendrocyte Maturation
- (2020) Bo-Ran Choi et al. Cell Reports
- Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia
- (2020) Basit Salik et al. CANCER CELL
- Evolving functions of Dickkopf-1 in cancer and immunity
- (2020) Nikolai Jaschke et al. CANCER LETTERS
- Phase 1b study of Wnt inhibitor ipafricept (IPA) with gemcitabine and nab-paclitaxel in patients with previously untreated stage IV pancreatic cancer (mPDAC).
- (2020) Efrat Dotan et al. CLINICAL CANCER RESEARCH
- Targeting Wnt/β‐catenin by anthelmintic drug niclosamide overcomes paclitaxel resistance in esophageal cancer
- (2020) Wei Wei et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- WNT Signaling in Melanoma
- (2020) Anna Gajos-Michniewicz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting the CBP/β-Catenin Interaction to Suppress Activation of Cancer-Promoting Pancreatic Stellate Cells
- (2020) Mingtian Che et al. Cancers
- Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome
- (2020) Je-Hwan Lee et al. Blood Advances
- Assembly of lung progenitors into developmentally-inspired geometry drives differentiation via cellular tension
- (2020) John P. Soleas et al. BIOMATERIALS
- Combined treatment with CBP and BET inhibitors reverses inadvertent activation of detrimental super enhancer programs in DIPG cells
- (2020) Maria Wiese et al. Cell Death & Disease
- 5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation
- (2020) Yong-Hee Cho et al. Nature Communications
- Aspirin Rescues Wnt-Driven Stem-like Phenotype in Human Intestinal Organoids and Increases the Wnt Antagonist Dickkopf-1
- (2020) Karen Dunbar et al. Cellular and Molecular Gastroenterology and Hepatology
- Hepatocyte growth factor/MET and CD44 in colorectal cancer: partners in tumorigenesis and therapy resistance
- (2020) Sander P.J. Joosten et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- WNT/β-catenin signaling in the development of liver cancers
- (2020) Shuai He et al. BIOMEDICINE & PHARMACOTHERAPY
- Frizzled-7 is required for Wnt signaling in gastric tumors with and without Apc mutations.
- (2019) Dustin Flanagan et al. CANCER RESEARCH
- Growth inhibition and apoptosis in colorectal cancer cells induced by Vitamin D-Nanoemulsion (NVD): involvement of Wnt/β-catenin and other signal transduction pathways
- (2019) Suhail Razak et al. Cell and Bioscience
- Gfi1b regulates the level of Wnt/β-catenin signaling in hematopoietic stem cells and megakaryocytes
- (2019) Peiman Shooshtarizadeh et al. Nature Communications
- Modulating Wnt signaling at the root: Porcupine and Wnt acylation
- (2019) Viviana I. Torres et al. PHARMACOLOGY & THERAPEUTICS
- Downregulation of RNF128 activates Wnt/β-catenin signaling to induce cellular EMT and stemness via CD44 and CTTN ubiquitination in melanoma
- (2019) Chuan-Yuan Wei et al. Journal of Hematology & Oncology
- Discovery and anticancer evaluation of a formononetin derivative against gastric cancer SGC7901 cells
- (2019) Jian-Ning Yao et al. INVESTIGATIONAL NEW DRUGS
- Inhibition of CBP/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells
- (2019) Robert Kleszcz et al. CELLULAR ONCOLOGY
- Distinct CRC-associated APC mutations dictate response to Tankyrase inhibition
- (2019) Emma M Schatoff et al. Cancer Discovery
- MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphoma
- (2019) Boheng Li et al. BLOOD
- A phase 1b dose escalation study of ipafricept (OMP 54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer
- (2019) Kathleen N. Moore et al. GYNECOLOGIC ONCOLOGY
- Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma
- (2019) Tan Boon Toh et al. JOURNAL OF HEPATOLOGY
- PORCN inhibition synergizes with PI3K/mTOR inhibition in Wnt-addicted cancers
- (2019) Zheng Zhong et al. ONCOGENE
- Temozolomide induces activation of Wnt/β-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy
- (2019) Vivek Singh Tomar et al. CELL BIOLOGY AND TOXICOLOGY
- Combined treatment with cisplatin and the tankyrase inhibitor XAV-939 increases cytotoxicity, abrogates cancer-stem-like cell phenotype and increases chemosensitivity of head-and-neck squamous-cell carcinoma cells
- (2019) Souvick Roy et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy
- (2019) Vikram Shaw et al. SEMINARS IN CANCER BIOLOGY
- USP7 inhibits Wnt/β-catenin signaling through promoting stabilization of Axin
- (2019) Lei Ji et al. Nature Communications
- An aggregon in conductin/axin2 regulates Wnt/β-catenin signaling and holds potential for cancer therapy
- (2019) Dominic B. Bernkopf et al. Nature Communications
- Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy
- (2019) Zuan-Fu Lim et al. Journal of Hematology & Oncology
- Biological activity of weekly ONC201 in adult recurrent glioblastoma patients
- (2019) Isabel Arrillaga-Romany et al. NEURO-ONCOLOGY
- In silico discovery of quinoxaline derivatives as novel LRP5/6-sclerostin interaction inhibitors
- (2018) Jiwon Choi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial
- (2018) Susen Burock et al. BMC CANCER
- A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients
- (2018) Anne-Laure Giraudet et al. BMC CANCER
- Gigantol inhibits Wnt/β-catenin signaling and exhibits anticancer activity in breast cancer cells
- (2018) Shubin Yu et al. BMC Complementary and Alternative Medicine
- IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft
- (2018) Sara R. Martins-Neves et al. CANCER LETTERS
- Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
- (2018) Nithya Krishnamurthy et al. CANCER TREATMENT REVIEWS
- Wnt signalling: conquering complexity
- (2018) Katrin E. Wiese et al. DEVELOPMENT
- Discovery and optimization of 1-(1 H -indol-1-yl)ethanone derivatives as CBP/EP300 bromodomain inhibitors for the treatment of castration-resistant prostate cancer
- (2018) Qiuping Xiang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a
- (2018) Man-Qing Cao et al. Journal of Hematology & Oncology
- A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphatase
- (2018) Jianbiao Zhou et al. Journal of Hematology & Oncology
- Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential
- (2018) Ingrid Spaan et al. Journal of Hematology & Oncology
- Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) δ/ε
- (2018) Balbina García-Reyes et al. JOURNAL OF MEDICINAL CHEMISTRY
- ONC201 Targets AR and AR-V7 Signaling, Reduces PSA, and Synergizes with Everolimus in Prostate Cancer
- (2018) Avital Lev et al. MOLECULAR CANCER RESEARCH
- A selective peptide inhibitor of Frizzled 7 receptors disrupts intestinal stem cells
- (2018) Aaron H. Nile et al. Nature Chemical Biology
- Is β-Catenin a Druggable Target for Cancer Therapy?
- (2018) Can Cui et al. TRENDS IN BIOCHEMICAL SCIENCES
- JIB-04, A Small Molecule Histone Demethylase Inhibitor, Selectively Targets Colorectal Cancer Stem Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway
- (2018) Min Seong Kim et al. Scientific Reports
- SCFβ-TRCP E3 ubiquitin ligase targets the tumor suppressor ZNRF3 for ubiquitination and degradation
- (2018) Yanpeng Ci et al. Protein & Cell
- Actinomycin-D and dimethylamino-parthenolide synergism in treating human pancreatic cancer cells
- (2018) Gauri Lamture et al. DRUG DEVELOPMENT RESEARCH
- The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5
- (2018) Meng Zhang et al. Journal of Hematology & Oncology
- Pimozide suppresses colorectal cancer via inhibition of Wnt/β-catenin signaling pathway
- (2018) Yonggang Ren et al. LIFE SCIENCES
- A synthetic anti-Frizzled antibody engineered for broadened specificity exhibits enhanced anti-tumor properties
- (2018) Zvezdan Pavlovic et al. mAbs
- Loss of RBMS3 Confers Platinum Resistance in Epithelial Ovarian Cancer via Activation of miR-126-5p/β-catenin/CBP signaling
- (2018) Geyan Wu et al. CLINICAL CANCER RESEARCH
- Inhibition of LEF1-Mediated DCLK1 by Niclosamide Attenuates Colorectal Cancer Stemness
- (2018) So-Yeon Park et al. CLINICAL CANCER RESEARCH
- A CK1α Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma
- (2018) Jezabel Rodriguez-Blanco et al. CLINICAL CANCER RESEARCH
- Wnt signaling dynamics in head and neck squamous cell cancer tumor-stroma interactions
- (2018) Phuong N. Le et al. MOLECULAR CARCINOGENESIS
- IC-2 Suppresses Proliferation and Induces Apoptosis of Bladder Cancer Cells via the Wnt/β-Catenin Pathway
- (2018) Lingfeng Wu et al. MEDICAL SCIENCE MONITOR
- USP25 regulates Wnt signaling by controlling the stability of tankyrases
- (2017) Daichao Xu et al. GENES & DEVELOPMENT
- Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity
- (2017) Simone Aparecida De Bessa Garcia et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress
- (2017) Afsane Bahrami et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Wnt/beta-catenin pathway: modulating anticancer immune response
- (2017) Sachin Gopalkrishna Pai et al. Journal of Hematology & Oncology
- GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP)
- (2017) F. Anthony Romero et al. JOURNAL OF MEDICINAL CHEMISTRY
- Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumors
- (2017) Bin Li et al. Science Signaling
- The lichen secondary metabolite atranorin suppresses lung cancer cell motility and tumorigenesis
- (2017) Rui Zhou et al. Scientific Reports
- Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy
- (2017) Chongyuan Zhang et al. MEDICAL SCIENCE MONITOR
- Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumors
- (2017) Bin Li et al. Science Signaling
- Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment
- (2017) Jeffrey Koury et al. Stem Cells International
- WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death
- (2017) Marcus M. Fischer et al. Science Advances
- Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors
- (2017) Varun V. Prabhu et al. PLoS One
- Development of a triazole class of highly potent Porcn inhibitors
- (2016) Lin You et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Enhanced targeting of CML stem and progenitor cells by inhibition of porcupine acyltransferase in combination with TKI
- (2016) Puneet Agarwal et al. BLOOD
- Simultaneous destabilization of β-catenin and Ras via targeting of the axin-RGS domain as a potential therapeutic strategy for colorectal cancer
- (2016) Pu-Hyeon Cha et al. BMB Reports
- Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway
- (2016) XUEFANG WU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells
- (2016) LIANG XU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Ursolic acid inhibits proliferation and induces apoptosis by inactivating Wnt/β-catenin signaling in human osteosarcoma cells
- (2016) Ran-Xi Zhang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Small-molecule binding of the axin RGS domain promotes β-catenin and Ras degradation
- (2016) Pu-Hyeon Cha et al. Nature Chemical Biology
- Discovery of Pyridinyl Acetamide Derivatives as Potent, Selective, and Orally Bioavailable Porcupine Inhibitors
- (2016) Dai Cheng et al. ACS Medicinal Chemistry Letters
- Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer
- (2016) Chi-Kang Lin et al. Oncotarget
- Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling
- (2016) Dan Liu et al. Oncotarget
- Triptonide Effectively Inhibits Wnt/β-Catenin Signaling via C-terminal Transactivation Domain of β-catenin
- (2016) Jessica Chinison et al. Scientific Reports
- Wnts are dispensable for differentiation and self-renewal of adult murine hematopoietic stem cells
- (2015) Z. Kabiri et al. BLOOD
- A Small-Molecule Antagonist of the -Catenin/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells and Suppresses Tumorigenesis
- (2015) L. Fang et al. CANCER RESEARCH
- Tankyrase Inhibition Blocks Wnt/ -Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer
- (2015) O. Arques et al. CLINICAL CANCER RESEARCH
- Targeting Wnt pathway in mantle cell lymphoma-initiating cells
- (2015) Rohit Mathur et al. Journal of Hematology & Oncology
- Discovery of Selective Small-Molecule Inhibitors for the β-Catenin/T-Cell Factor Protein–Protein Interaction through the Optimization of the Acyl Hydrazone Moiety
- (2015) J. Leon Catrow et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dishevelled Promotes Wnt Receptor Degradation through Recruitment of ZNRF3/RNF43 E3 Ubiquitin Ligases
- (2015) Xiaomo Jiang et al. MOLECULAR CELL
- Wnt addiction of genetically defined cancers reversed by PORCN inhibition
- (2015) B Madan et al. ONCOGENE
- Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer
- (2015) Mari Masuda et al. PHARMACOLOGY & THERAPEUTICS
- Targeting the Wnt pathway in human cancers: Therapeutic targeting with a focus on OMP-54F28
- (2015) Phuong N. Le et al. PHARMACOLOGY & THERAPEUTICS
- Tankyrase Inhibition Causes Reversible Intestinal Toxicity in Mice with a Therapeutic Index < 1
- (2015) Yu Zhong et al. TOXICOLOGIC PATHOLOGY
- Wnt-C59 arrests stemness and suppresses growth of nasopharyngeal carcinoma in mice by inhibiting the Wnt pathway in the tumor microenvironment
- (2015) Yue Cheng et al. Oncotarget
- Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice
- (2015) Yosuke Osawa et al. EBioMedicine
- Wnt inhibition leads to improved chemosensitivity in paediatric acute lymphoblastic leukaemia
- (2014) Smita Dandekar et al. BRITISH JOURNAL OF HAEMATOLOGY
- Safely targeting cancer stem cells via selective catenin coactivator antagonism
- (2014) Heinz-Josef Lenz et al. CANCER SCIENCE
- Isoquercitrin Suppresses Colon Cancer Cell Growthin Vitroby Targeting the Wnt/β-Catenin Signaling Pathway
- (2014) Nathália G. Amado et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Salinomycin Suppresses LRP6 Expression and Inhibits Both Wnt/β-catenin and mTORC1 Signaling in Breast and Prostate Cancer Cells
- (2014) Wenyan Lu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- High-Throughput Drug Screen Identifies Chelerythrine as a Selective Inducer of Death in a TSC2-null Setting
- (2014) Doug Medvetz et al. MOLECULAR CANCER RESEARCH
- Effect of Niclosamide on Basal-like Breast Cancers
- (2014) A. I. Londono-Joshi et al. MOLECULAR CANCER THERAPEUTICS
- Can we safely target the WNT pathway?
- (2014) Michael Kahn NATURE REVIEWS DRUG DISCOVERY
- The Anthelmintic Drug Niclosamide Induces Apoptosis, Impairs Metastasis and Reduces Immunosuppressive Cells in Breast Cancer Model
- (2014) Tinghong Ye et al. PLoS One
- Targeting the Wnt/β-Catenin Signaling Pathway in Liver Cancer Stem Cells and Hepatocellular Carcinoma Cell Lines with FH535
- (2014) Roberto Gedaly et al. PLoS One
- Roles of Wnt/β-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment
- (2014) J Mao et al. Cell Death & Disease
- The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma
- (2013) E Sánchez-Tilló et al. CELL DEATH AND DIFFERENTIATION
- Hematein, a casein kinase II inhibitor, inhibits lung cancer tumor growth in a murine xenograft model
- (2013) MING-SZU HUNG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- XAV939, a tankyrase 1 inhibitior, promotes cell apoptosis in neuroblastoma cell lines by inhibiting Wnt/β-catenin signaling pathway
- (2013) Xiao-Hong Tian et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells
- (2013) Birdal Bilir et al. Journal of Translational Medicine
- Sulindac Selectively Inhibits Colon Tumor Cell Growth by Activating the cGMP/PKG Pathway to Suppress Wnt/ -Catenin Signaling
- (2013) N. Li et al. MOLECULAR CANCER THERAPEUTICS
- Wogonin induced G1 cell cycle arrest by regulating Wnt/β-catenin signaling pathway and inactivating CDK8 in human colorectal cancer carcinoma cells
- (2013) Licheng He et al. TOXICOLOGY
- Structural and molecular basis of ZNRF3/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondin
- (2013) Matthias Zebisch et al. Nature Communications
- The tankyrase-specific inhibitor JW74 affects cell cycle progression and induces apoptosis and differentiation in osteosarcoma cell lines
- (2013) Eva Wessel Stratford et al. Cancer Medicine
- Trifluoperazine, an Antipsychotic Agent, Inhibits Cancer Stem Cell Growth and Overcomes Drug Resistance of Lung Cancer
- (2012) Chi-Tai Yeh et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling
- (2012) Alfiya Distler et al. ANNALS OF THE RHEUMATIC DISEASES
- Celecoxib Downregulates CD133 Expression Through Inhibition of the Wnt Signaling Pathway in Colon Cancer Cells
- (2012) Yanhong Deng et al. CANCER INVESTIGATION
- A Novel Tankyrase Inhibitor Decreases Canonical Wnt Signaling in Colon Carcinoma Cells and Reduces Tumor Growth in Conditional APC Mutant Mice
- (2012) J. Waaler et al. CANCER RESEARCH
- A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling
- (2012) Masamichi Imajo et al. EMBO JOURNAL
- Nimbolide, a neem limonoid abrogates canonical NF-κB and Wnt signaling to induce caspase-dependent apoptosis in human hepatocarcinoma (HepG2) cells
- (2012) Krishnamurthy Kavitha et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Tankyrase-targeted therapeutics: expanding opportunities in the PARP family
- (2012) Jenna L. Riffell et al. NATURE REVIEWS DRUG DISCOVERY
- Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
- (2012) A. Gurney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hippo pathway in intestinal homeostasis and tumorigenesis
- (2012) Lanfen Chen et al. Protein & Cell
- Salinomycin inhibits osteosarcoma by targeting its tumor stem cells
- (2011) Qing-Lian Tang et al. CANCER LETTERS
- Phospho-Sulindac (OXT-328) Combined with Difluoromethylornithine Prevents Colon Cancer in Mice
- (2011) Gerardo G. Mackenzie et al. Cancer Prevention Research
- Novel Synthetic Antagonists of Canonical Wnt Signaling Inhibit Colorectal Cancer Cell Growth
- (2011) J. Waaler et al. CANCER RESEARCH
- Small molecule-based disruption of the Axin/β-catenin protein complex regulates mesenchymal stem cell differentiation
- (2011) Jungsug Gwak et al. CELL RESEARCH
- Attenuation of multi-targeted proliferation-linked signaling by 3,3′-diindolylmethane (DIM): From bench to clinic
- (2011) Sanjeev Banerjee et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells
- (2011) Desheng Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells?
- (2010) F. Takahashi-Yanaga et al. CLINICAL CANCER RESEARCH
- Role of Wnt canonical pathway in hematological malignancies
- (2010) Xueling GE et al. Journal of Hematology & Oncology
- Convergence between Wnt-β-catenin and EGFR signaling in cancer
- (2010) Tianhui Hu et al. Molecular Cancer
- Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
- (2010) Curtis A Thorne et al. Nature Chemical Biology
- Targeting cancer stem cells by inhibiting Wnt, Notch and Hedgehog pathways
- (2010) Naoko Takebe et al. Nature Reviews Clinical Oncology
- Cellular signaling perturbation by natural products
- (2009) Fazlul H. Sarkar et al. CELLULAR SIGNALLING
- Discovery and Characterization of a Small Molecule Inhibitor of the PDZ Domain of Dishevelled
- (2009) David Grandy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
- (2009) Shih-Min A. Huang et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now